{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:31:39Z","timestamp":1790854299614,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.lpm.2007.02.029","type":"journal-article","created":{"date-parts":[[2008,1,26]],"date-time":"2008-01-26T05:54:08Z","timestamp":1201326848000},"page":"999-1006","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Prise en\u00a0charge du\u00a0post-infarctus"],"prefix":"10.1016","volume":"36","author":[{"given":"Jean-Pierre","family":"Monassier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Monassier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2007.02.029_bib1","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/0735-1097(94)00552-2","article-title":"Treatment with Beta-Adrenergic Blocking Agents after myocardial infarction: from randomized trials to clinical practice","volume":"25","author":"Viskin","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2007.02.029_bib2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib3","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1016\/S0735-1097(99)00383-6","article-title":"Beta-Blocker therapy for secondary prevention of myocardial infarction in elderly diabetic patients. Results from the National Cooperative Cardiovascular Project","volume":"34","author":"Chen","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.lpm.2007.02.029_bib4","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction: results of the Survival and Ventricular Enlargement Trial","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib5","first-page":"821","article-title":"Effect of ramipril on mortality and morbidity of survivors of survivors of acute myocardial infarction with clinical evidence of heart failure","volume":"3","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib6","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"for the Trandolapril Cardiac Evaluation (TRACE) study group: A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib7","first-page":"1115","article-title":"GISSI-3: effects of lisinopril and transdermal glycerol trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib8","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/0140-6736(92)92889-N","article-title":"Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fraction","volume":"340","author":"Yusuf","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib9","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1067\/mhj.2003.24","volume":"145","author":"Borghi","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.lpm.2007.02.029_bib10","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0140-6736(03)14974-4","volume":"362","author":"Fox","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib11","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0140-6736(02)11138-X","article-title":"ACE Inhibitors Collaborative Group. Effects of long-term treatment with angiotensin-converting \u2013 enzyme inhibitors in the presence or absence of aspirin: a systematic review","volume":"360","author":"Teo","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib12","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, Captopril or both in myocardial infarction complicated by heart failure, left ventricular dysfunction or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib13","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S0140-6736(01)05701-4","article-title":"Effects of pre-treatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study","volume":"358","author":"Mehta","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib14","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1001\/jama.288.19.2411","article-title":"Clopidogrel for the reduction of events during observation: early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomised controlled trial","volume":"288","author":"Steinhubl","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2007.02.029_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","article-title":"Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients","volume":"324","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2007.02.029_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0140-6736(02)09409-6","article-title":"Antithromboticx in the secondary prevention of events in coronary thrombosis-2 (ASPECT 2) research group","volume":"360","author":"van Es","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.lpm.2007.02.029_bib17","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1056\/NEJMoa020496","article-title":"Warfarin, Aspirin or both after myocardial infarction","volume":"347","author":"Hurlen","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib18","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.0000133317.49796.0E","article-title":"for the coordinating committee of the National Cholesterol Education Program. Implications of recent clinical trials for National Cholesterol Education Program adult treatment Panel III guidelines","volume":"110","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.02.029_bib19","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1161\/01.CIR.0000032466.44170.44","article-title":"writing committee members. ACC\/AHA\/NHLBI Clinical advisory on the use and safety of statins","volume":"106","author":"Pasternak","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.02.029_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1056\/NEJMoa042378","article-title":"(PROVE IT-TIMI 22) investigators. C-Reactive protein levels and outcomes after statin therapy","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib22","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib23","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1161\/01.CIR.0000014682.14181.F2","volume":"105","author":"Marchioli","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.02.029_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascullar and microvascular complications on type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.lpm.2007.02.029_bib25","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and low ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0735-1097(03)00092-5","article-title":"Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction","volume":"41","author":"Menasche","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"suppl H","key":"10.1016\/j.lpm.2007.02.029_bib27","doi-asserted-by":"crossref","first-page":"H3","DOI":"10.1093\/eurheartj\/sul062","article-title":"Which patients with ischaemic heart disease could benefit from cell replacement therapy?","volume":"8","author":"Lipiecki","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.lpm.2007.02.029_bib28","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1056\/NEJMra001529","article-title":"Cardiac rehabilitation and secondary prevention of coronary artery disease","volume":"345","author":"Ades","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib29","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1161\/01.CIR.89.3.975","article-title":"Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: the Stanford Coronary Risk Intervention Project (SCRIP)","volume":"89","author":"Haskell","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.02.029_bib30","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1001\/jama.280.23.2001","article-title":"Intensive lifestyle changes for reversal of coronary heart disease","volume":"280","author":"Ornish","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.lpm.2007.02.029_bib31","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1161\/01.CIR.96.8.2534","article-title":"Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention: role of physical exercise","volume":"96","author":"Niebauer","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.lpm.2007.02.029_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1056\/NEJM200002173420702","article-title":"Effect of exercise on coronary endothelial function in patients with coronary artery disease","volume":"342","author":"Hambrecht","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2007.02.029_bib33","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1161\/01.CIR.102.12.1358","article-title":"Physical activity and mortality in older men with diagnosed coronary heart disease","volume":"102","author":"Wannamethee","year":"2000","journal-title":"Circulation"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207002941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498207002941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T07:53:26Z","timestamp":1546329206000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498207002941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S0755498207002941"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2007.02.029","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}